Literature DB >> 29288676

Transcriptomic profiles of post-smolt Atlantic salmon challenged with Piscirickettsia salmonis reveal a strategy to evade the adaptive immune response and modify cell-autonomous immunity.

Marco Rozas-Serri1, Andrea Peña2, Lucerina Maldonado3.   

Abstract

Piscirickettsiosis is the main bacterial disease affecting the Chilean salmon farming industry and is responsible for high economic losses. The development of effective strategies to control piscirickettsiosis has been limited in part by insufficient knowledge of the host response. The aim of this study was to use RNA sequencing to describe the transcriptional profiles of the responses of post-smolt Atlantic salmon infected with LF-89-like or EM-90-like Piscirickettsia salmonis. Enrichment and pathway analyses of the differentially expressed genes revealed several central signatures following infection, including positive regulation of DC-SIGN and TLR5 signalling, which converged at the NF-κB level to modulate the pro-inflammatory cytokine response, particularly in the PS-EM-90-infected fish. P. salmonis induced an IFN-inducible response (e.g., IRF-1 and GBP-1) but inhibited the humoral and cell-mediated immune responses. P. salmonis induced significant cytoskeletal reorganization but decreased lysosomal protease activity and caused the degradation of proteins associated with cellular stress. Infection with these isolates also delayed protein transport, antigen processing, vesicle trafficking and autophagy. Both P. salmonis isolates promoted cell survival and proliferation and inhibited apoptosis. Both groups of Trojan fish used similar pathways to modulate the immune response at 5 dpi, but the transcriptomic profiles in the head kidneys of the cohabitant fish infected with PS-LF-89 and PS-MS-90 were relatively different at day 35 post-infection of the Trojan fish, probably due to the different degree of pathogenicity of each isolate. Our study showed the most important biological mechanisms used by P. salmonis, regardless of the isolate, to evade the immune response, maintain the viability of host cells and increase intracellular replication and persistence at the infection site. These results improve the understanding of the mechanisms by which P. salmonis interacts with its host and may serve as a basis for the development of effective strategies for the control of piscirickettsiosis.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EM-90; LF-89; Piscirickettsia salmonis; Piscirickettsiosis; RNA-seq

Mesh:

Substances:

Year:  2017        PMID: 29288676     DOI: 10.1016/j.dci.2017.12.023

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  13 in total

1.  Cellular stress responses of Eleginops maclovinus fish injected with Piscirickettsia salmonis and submitted to thermal stress.

Authors:  D Martínez; C Vargas-Lagos; J Saravia; R Oyarzún; C Loncoman; J P Pontigo; L Vargas-Chacoff
Journal:  Cell Stress Chaperones       Date:  2019-12-13       Impact factor: 3.667

2.  Temporal genome-wide DNA methylation signature of post-smolt Pacific salmon challenged with Piscirickettsia salmonis.

Authors:  Francisco Leiva; Scarlet Bravo; Killen Ko Garcia; Javier Moya; Osiel Guzman; Nicolás Bascuñan; Rodrigo Vidal
Journal:  Epigenetics       Date:  2020-12-31       Impact factor: 4.528

3.  Immunomodulatory Effects of Dietary Seaweeds in LPS Challenged Atlantic Salmon Salmo salar as Determined by Deep RNA Sequencing of the Head Kidney Transcriptome.

Authors:  Arjan P Palstra; Jeroen Kals; Ainhoa Blanco Garcia; Ron P Dirks; Marnix Poelman
Journal:  Front Physiol       Date:  2018-06-01       Impact factor: 4.566

4.  Global Proteomic Profiling of Piscirickettsia salmonis and Salmon Macrophage-Like Cells during Intracellular Infection.

Authors:  Javiera Ortiz-Severín; Dante Travisany; Alejandro Maass; Verónica Cambiazo; Francisco P Chávez
Journal:  Microorganisms       Date:  2020-11-24

5.  Investigating mechanisms underlying genetic resistance to Salmon Rickettsial Syndrome in Atlantic salmon using RNA sequencing.

Authors:  Carolina P Moraleda; Diego Robledo; Alejandro P Gutiérrez; Jorge Del-Pozo; José M Yáñez; Ross D Houston
Journal:  BMC Genomics       Date:  2021-03-06       Impact factor: 3.969

6.  "Limiting access to iron decreases infection of Atlantic salmon SHK-1 cells with bacterium Piscirickettsia salmonis".

Authors:  Rodrigo Díaz; José Troncoso; Eva Jakob; Stanko Skugor
Journal:  BMC Vet Res       Date:  2021-04-13       Impact factor: 2.741

7.  Interferon Gamma Induces the Increase of Cell-Surface Markers (CD80/86, CD83 and MHC-II) in Splenocytes From Atlantic Salmon.

Authors:  Byron Morales-Lange; Felipe Ramírez-Cepeda; Paulina Schmitt; Fanny Guzmán; Leidy Lagos; Margareth Øverland; Valentina Wong-Benito; Mónica Imarai; Derie Fuentes; Sebastián Boltaña; Javier Alcaíno; Carlos Soto; Luis Mercado
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

8.  Atlantic Salmon Pre-smolt Survivors of Renibacterium salmoninarum Infection Show Inhibited Cell-Mediated Adaptive Immune Response and a Higher Risk of Death During the Late Stage of Infection at Lower Water Temperatures.

Authors:  Marco Rozas-Serri; Carlos Lobos; Rodolfo Correa; Ricardo Ildefonso; Jorge Vásquez; Ariel Muñoz; Lucerina Maldonado; Victoria Jaramillo; Darling Coñuecar; Camila Oyarzún; Romina Walker; Carolina Navarrete; Jorge Gayosa; Patricio Mancilla; Andrea Peña; Carolina Senn; Francisco Schwerter
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

9.  Multi-Tissue Transcriptome Profiling of North American Derived Atlantic Salmon.

Authors:  Amin R Mohamed; Harry King; Bradley Evans; Antonio Reverter; James W Kijas
Journal:  Front Genet       Date:  2018-09-13       Impact factor: 4.599

10.  Host genetic variation explains reduced protection of commercial vaccines against Piscirickettsia salmonis in Atlantic salmon.

Authors:  Carolina Figueroa; Pamela Veloso; Lenin Espin; Brian Dixon; Débora Torrealba; Islam Said Elalfy; Juan Manuel Afonso; Carlos Soto; Pablo Conejeros; José A Gallardo
Journal:  Sci Rep       Date:  2020-10-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.